137 related articles for article (PubMed ID: 34572945)
1. Reproducibility of mRNA-Based Testing of
Erber R; Hartmann A; Fasching PA; Ruebner M; Stöhr R; Beckmann MW; Zentgraf M; Popp V; Weidler J; Simon I; Becker S; Huebner H; Fischer J; Guerini Rocco E; Viale G; Cayre A; Penault-Llorca F; Caniego Casas T; Pérez-Miés B; Palacios J; Jank P; Denkert C; Khoury L; Mairinger T; Ferrazzi F
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572945
[TBL] [Abstract][Full Text] [Related]
2. ESR1, PGR, ERBB2, and MKi67 mRNA expression in postmenopausal women with hormone receptor-positive early breast cancer: results from ABCSG Trial 6.
Filipits M; Rudas M; Singer CF; Fitzal F; Bago-Horvath Z; Greil R; Balic M; Lax SF; Halper S; Hulla W; Wu NC; Liu X; Weidler J; Bates M; Hlauschek D; Gnant M; Dubsky P
ESMO Open; 2021 Aug; 6(4):100228. PubMed ID: 34371382
[TBL] [Abstract][Full Text] [Related]
3. Comparison of central laboratory assessments of ER, PR, HER2, and Ki67 by IHC/FISH and the corresponding mRNAs (ESR1, PGR, ERBB2, and MKi67) by RT-qPCR on an automated, broadly deployed diagnostic platform.
Wu NC; Wong W; Ho KE; Chu VC; Rizo A; Davenport S; Kelly D; Makar R; Jassem J; Duchnowska R; Biernat W; Radecka B; Fujita T; Klein JL; Stonecypher M; Ohta S; Juhl H; Weidler JM; Bates M; Press MF
Breast Cancer Res Treat; 2018 Nov; 172(2):327-338. PubMed ID: 30120700
[TBL] [Abstract][Full Text] [Related]
4. Use of the Xpert Breast Cancer STRAT4 for Biomarker Evaluation in Tissue Processed in a Developing Country.
Mugabe M; Ho KE; Ruhangaza D; Milner D; Rugwizangoga B; Chu VC; Wu NC; Rizo A; Weidler JM; Wong W; Bates M; Brock JE
Am J Clin Pathol; 2021 Oct; 156(5):766-776. PubMed ID: 34050358
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of
Carretero-Barrio I; Caniego-Casas T; Rosas M; Sánchez MC; Martínez-Jáñez N; Chiva M; Sarrió D; Moreno-Bueno G; Palacios J; Pérez-Mies B
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980575
[TBL] [Abstract][Full Text] [Related]
6. Comparison of breast cancer surrogate subtyping using a closed-system RT-qPCR breast cancer assay and immunohistochemistry on 100 core needle biopsies with matching surgical specimens.
Janeva S; Parris TZ; Nasic S; De Lara S; Larsson K; Audisio RA; Olofsson Bagge R; Kovács A
BMC Cancer; 2021 Apr; 21(1):439. PubMed ID: 33879115
[TBL] [Abstract][Full Text] [Related]
7. Technical validation of an RT-qPCR in vitro diagnostic test system for the determination of breast cancer molecular subtypes by quantification of ERBB2, ESR1, PGR and MKI67 mRNA levels from formalin-fixed paraffin-embedded breast tumor specimens.
Laible M; Schlombs K; Kaiser K; Veltrup E; Herlein S; Lakis S; Stöhr R; Eidt S; Hartmann A; Wirtz RM; Sahin U
BMC Cancer; 2016 Jul; 16():398. PubMed ID: 27389414
[TBL] [Abstract][Full Text] [Related]
8. Comparison of immunohistochemistry and RT-qPCR for assessing ER, PR, HER2, and Ki67 and evaluating subtypes in patients with breast cancer.
Chen L; Chen Y; Xie Z; Luo J; Wang Y; Zhou J; Huang L; Li H; Wang L; Liu P; Shu M; Zhang W; Ke Z
Breast Cancer Res Treat; 2022 Aug; 194(3):517-529. PubMed ID: 35789315
[TBL] [Abstract][Full Text] [Related]
9. Validation of the Xpert Breast Cancer STRAT 4 Assay on the GeneXpert instrument to Assess Hormone Receptor, Ki67, and HER2 Gene Expression Status in Breast Cancer Tissue Samples.
Sewanywa L; Hale M; Michelow P; Mayne E; Wiggill T
Appl Immunohistochem Mol Morphol; 2023 Oct; 31(9):613-620. PubMed ID: 37800656
[TBL] [Abstract][Full Text] [Related]
10. An international reproducibility study validating quantitative determination of ERBB2, ESR1, PGR, and MKI67 mRNA in breast cancer using MammaTyper®.
Varga Z; Lebeau A; Bu H; Hartmann A; Penault-Llorca F; Guerini-Rocco E; Schraml P; Symmans F; Stoehr R; Teng X; Turzynski A; von Wasielewski R; Gürtler C; Laible M; Schlombs K; Joensuu H; Keller T; Sinn P; Sahin U; Bartlett J; Viale G
Breast Cancer Res; 2017 May; 19(1):55. PubMed ID: 28490348
[TBL] [Abstract][Full Text] [Related]
11. Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer.
Sinn HP; Schneeweiss A; Keller M; Schlombs K; Laible M; Seitz J; Lakis S; Veltrup E; Altevogt P; Eidt S; Wirtz RM; Marmé F
BMC Cancer; 2017 Feb; 17(1):124. PubMed ID: 28193205
[TBL] [Abstract][Full Text] [Related]
12. Biological subtyping of early breast cancer: a study comparing RT-qPCR with immunohistochemistry.
Wirtz RM; Sihto H; Isola J; Heikkilä P; Kellokumpu-Lehtinen PL; Auvinen P; Turpeenniemi-Hujanen T; Jyrkkiö S; Lakis S; Schlombs K; Laible M; Weber S; Eidt S; Sahin U; Joensuu H
Breast Cancer Res Treat; 2016 Jun; 157(3):437-46. PubMed ID: 27220750
[TBL] [Abstract][Full Text] [Related]
13. Concordance between ER, PR, Ki67, and HER2-low expression in breast cancer by MammaTyper RT-qPCR and immunohistochemistry: implications for the practising pathologist.
Badr NM; Zaakouk M; Zhang Q; Kearns D; Kong A; Shaaban AM
Histopathology; 2024 Apr; ():. PubMed ID: 38651302
[TBL] [Abstract][Full Text] [Related]
14. XPERT
Borges PCC; Spencer HB; Barbosa C; Costa V; Furtado A; Leal MC; Lopes C; Ferreira D; Carvalho AL; Dos-Santos-Silva I; Santos LL
Ecancermedicalscience; 2023; 17():1530. PubMed ID: 37138965
[TBL] [Abstract][Full Text] [Related]
15. ESR1, ERBB2, and Ki67 mRNA expression predicts stage and grade of non-muscle-invasive bladder carcinoma (NMIBC).
Breyer J; Wirtz RM; Laible M; Schlombs K; Erben P; Kriegmair MC; Stoehr R; Eidt S; Denzinger S; Burger M; Hartmann A; Otto W
Virchows Arch; 2016 Nov; 469(5):547-552. PubMed ID: 27514658
[TBL] [Abstract][Full Text] [Related]
16. Breast Cancer Subtype Classification Using 4-Plex Droplet Digital PCR.
Chen W; Zheng J; Wu C; Liu S; Chen Y; Liu X; Du J; Wang J
Clin Chem; 2019 Aug; 65(8):1051-1059. PubMed ID: 31010819
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive and Accurate Molecular Profiling of Breast Cancer through mRNA Expression of
Wegscheider AS; Gorniak J; Rollinson S; Gough L; Dhaliwal N; Guardiola A; Gasior A; Helmer D; Pounce Z; Niendorf A
Diagnostics (Basel); 2024 Jan; 14(3):. PubMed ID: 38337757
[TBL] [Abstract][Full Text] [Related]
18. The detection of ESR1/PGR/ERBB2 mRNA levels by RT-QPCR: a better approach for subtyping breast cancer and predicting prognosis.
Du X; Li XQ; Li L; Xu YY; Feng YM
Breast Cancer Res Treat; 2013 Feb; 138(1):59-67. PubMed ID: 23397283
[TBL] [Abstract][Full Text] [Related]
19. Tumor biomarker conversion between primary and metastatic breast cancer: mRNA assessment and its concordance with immunohistochemistry.
Stefanovic S; Wirtz R; Deutsch TM; Hartkopf A; Sinn P; Varga Z; Sobottka B; Sotiris L; Taran FA; Domschke C; Hennigs A; Brucker SY; Sohn C; Schuetz F; Schneeweiss A; Wallwiener M
Oncotarget; 2017 Aug; 8(31):51416-51428. PubMed ID: 28881657
[TBL] [Abstract][Full Text] [Related]
20. Automated Classification of Breast Cancer Across the Spectrum of
Guvakova MA
JCO Clin Cancer Inform; 2023 Jul; 7():e2300013. PubMed ID: 37437225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
